DOCSLIB.ORG

Spectrum of Breast Disorders in a Pediatric Surgery Clinic: Retrospective Study

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Spectrum of Breast Disorders in a Pediatric Surgery Clinic: Retrospective Study Article ID: WMC003775 ISSN 2046-1690 Spectrum of Breast Disorders in A Pediatric Surgery Clinic: Retrospective Study Corresponding Author: Dr. Atilla Senayli, Assistant Prof., Pediatric Surgery, Yildirim Beyazit University - Turkey Submitting Author: Dr. Atilla Senayli, Assistant Prof., Pediatric Surgery, Yildirim Beyazit University - Turkey Article ID: WMC003775 Article Type: Original Articles Submitted on:26-Oct-2012, 05:59:39 AM GMT Published on: 26-Oct-2012, 06:25:34 PM GMT Article URL: http://www.webmedcentral.com/article_view/3775 Subject Categories:PAEDIATRIC SURGERY Keywords:Breast; Disorders; Children How to cite the article:Senayli A, Karaveliolu A , Koseoglu B , Akln M , Ozguner I . Spectrum of Breast Disorders in A Pediatric Surgery Clinic: Retrospective Study . WebmedCentral PAEDIATRIC SURGERY 2012;3(10):WMC003775 Copyright: This is an open-access article distributed under the terms of the Creative Commons Attribution License(CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Source(s) of Funding: None Competing Interests: None WebmedCentral > Original Articles Page 1 of 7 WMC003775 Downloaded from http://www.webmedcentral.com on 26-Oct-2012, 06:25:34 PM Spectrum of Breast Disorders in A Pediatric Surgery Clinic: Retrospective Study Author(s): Senayli A, Karaveliolu A , Koseoglu B , Akln M , Ozguner I Abstract Paediatricians must pay attention to breast disorders that may be seen at any paediatric age group. (1). Objective: There are a limited and inadequate data Although most of the diseases are benign as a fact, for breast diseases in children. This may be because the possibility of malignancy can never be ignored of low importance expectations of practitioners' for (1-3). The major problem to form a confident clinical breast problems in which laboratory tools are treatment protocol is very little published data for rarely used. However, breast issues of children may breast diseases of adolescence (2,3). possibly remain missing as a consequence of Underestimation of the breast disorders often by insufficient data. In this article, we encourage the clinicians may be the reason of publication authors to share their experiences and publish deficiencies (4). On contrary to this, breast disorders procedures. of children and adolescent must be important topics for physicians and gynecologist (4). Parents anxiety Settings and Methods: Pediatric surgery documents and patients’ fear about progressive breast disorders between 2005 and 2011 were evaluated to are the main reason of this suggestion (4). demonstrate breast disorders. Diagnosis, gender, age, More data is needed to make decisions on breast ultrasonography, treatment modalities and follow-up diseases. For data expansion, we aim to add 6-year procedures were studied in this study. Literature data experience for breast diseases to literature. is compared with the study findings. What could be the lack of practice due to lack of data in the literature are Methods presented. Results: Seventy-two patients were diagnosed with In Kecioren Education Hospital, documents of breast diseases among 9958 patients. Twenty-eight pediatric surgery between 2005 and 2011 were patients were male and 44 patients were female. evaluated for breast diseases. Some of the authors Median ages of the male and female patients were contributing to this study previously worked in the 12.5 and 14 respectively. Physical examination was hospital. Some authors are still working. In this study, the only practice used for most patients. spectrum of breast disorders, gender, age, Ultrasonography was used for 27 patients. Laboratory ultrasonography, treatment modalities, and follow-up examinations were not used. Only one patient was periods are presented. Diseases were evaluated with operated. Male and female patients were followed for International Classification of Diseases Code-10 2 and 3 years, respectively. (ICD-10). Authors had agreed on similar codes for diagnosis of unknown lesions like masses. Most of Conclusion: Although literature data is present for undefined masses were diagnosed as “Benign Breast breast disorders, clinical documents published by Dysplasia”. paediatric surgery on this subject is rare. Simple treatment modalities, necessity of long follow-up Results periods and clinically unimportant disorders may be the reason of very little published information. Different managements and experiences for breast diseases Seventy-two patients were diagnosed with breast must be published to add value to a lacking and disease in 9958 cases. Twenty-eight patients were neglected issue. The only mission of this study is to male and 44 patients were female. Median ages of the invite authors all over the world to add their data about male and female patients were 12.5 and 14 breast disorders. respectively. Accessory breast (1 patient, 1.4%), benign breast dysplasia (51 patients, 70.8%), Introduction gynecomastia (6 patients, 8.4%), breast hypertrophy (4 patients, 5.5 %), non-puerperal infective mastitis (4 WebmedCentral > Original Articles Page 2 of 7 WMC003775 Downloaded from http://www.webmedcentral.com on 26-Oct-2012, 06:25:34 PM patients, 5.5 %), non-puerperal breast abscess (3 Therefore, we performed a randomized treatment. We patients, 4.2%), nipple fissure (2 patients, 2.8%), and invite authors to share their experience in this regard. diffuse breast cyst (1 patient, 1.4%) was the result of Otherwise, the disease can’t be formulated for better the study. Breast ultrasonography was used for 27 decision-making. patients. Very few patients had blood samples and other laboratory tests were performed. Therefore, Breast masses have usually been diagnosed as laboratory studies are not included in article. Physical benign physiologic enlargements or developmental examination has been the main assessment and changes (6). Fibroadenoma is the most seen benign management tool. Only one patient was operated. dysplasia of female (1-3). Fibroadenoma could be Male and female patients were followed-up for 3 and 2 72-75% of the breast masses (4). In our series, 70.8% years respectively. Results were demonstrated in patients (n=51/72) were diagnosed with benign breast Table-1. dysplasia. In International coding system for diseases is limited on breast problems. Seeing this, “Benign Discussion Breast Dysplasia” was preferred for the description of breast masses in our practice. Thirty patients (30/72, 41.6%) in this group were female and all female Breast disorders can be diagnosed also in children patients had fibroadenoma. Fibroadenomas are (3,5). Although most breast disorders of this age are estrogen-sensitive tumors. Due to this sensitivity, benign, parents are always fear of malignancy (1). fibroadenomas can be seen in patients premenarchal Parents' concerns are the most effective factor for the and 20 years old (4). Patients, in our study, are found treatment of breast disorders. Sometimes, these to be premenarchal or older, as mentioned in literature. concerns may force physicians for surgical Ultrasound (US) is important for the diagnosis of intervention. Physicians must know the process of breast disorders especially masses (1,2). Only 13 these diseases at adolescence to do the right thing for ultrasonography examinations were performed for the child and to convince parents. In contrast, the female patients in this group and therefore, the literature contains adolescence diseases is limited, number of evaluations for diagnosis may be accepted and physicians have often overlooked the diseases. insufficient. Typical physical examination findings of breast masses may be one of the reasons. Low Breast problems are rarely examined in pediatric expectations for USG findings about the masses of surgery clinics. Therefore, collections of the patients' patients may be another important reason. Also, data at any number will be meaningful. Total number follow-up decisions of the authors may interrupt of our patients is 72. Nevertheless, we share our ultrasonography evaluations. experience for accessory breast, benign breast dysplasia, gynecomastia, breast hypertrophy, Breast masses, particularly fibroadenoma, due to the non-puerperal infective mastitis, non-puerperal breast menstrual cycle can be treated with hormones. For abscess, nipple fissure and diffuse breast cyst. this purpose, to monitor two or three menstrual cycles, may be sufficient to decide (1). However, to our Accessory breast is a true polymastia containing all knowledge, management schedule of these problems components of mammary but the disease forms a is not present, yet. In this section; the breast masses small percentage of the polymastia disorders. (5). variations, ultrasound necessity, sufficiency of Polythelia, the existence of accessory nipple and ultrasound, or predicting factors are still unknown. In areolae, is the most seen anomaly of this issue. (5). In fact, we realize that our data was also defective for all literature, enough data about the demography, these factors. Therefore, practices in our clinic will also characteristics and statistics for accessory breast be revised. disorders has not been collected. In our clinics, only one case was present and the disease was at the On the other hand, twenty-one male patients (21/72, axillary region. Ultrasonography was used for the 29%) were diagnosed with benign breast dysplasia. confirmation of disease. At the same time, she was the Median age of these patients was 12 and only 6 were only
Load more

Recommended publications
  • Back Pain: an Assessment in Breast Hypertrophy Patients
    ORIGINAL ARTICLE BACK PAIN: AN ASSESSMENT IN BREAST HYPERTROPHY PATIENTS PAULO MAGALHÃES FERNANDES1, MIGUEL SABINO NETO2, DANIELA FRANCESCATO VEIGA3, LUIS EDUARDODUARDO FELIPE ABLABLA4, CARLOS DELANO ARAÚJO MUNDIM 5, YARAARA JULIANOULIANO6,� LYDIAYDIA MASAKOASAKO FERREIRAERREIRA7 SUMMARY used in order to evaluate the magnitude of back pain and Objective – To evaluate the influence of breast hypertrophy on the limitations arising from these symptoms. Results – The the incidence of back pain and how much they can interfere in mean age of the patients in the study group was 32.2 years patients’ daily activities. Methods – This was a cross-sectional and 32.7 for the control group. The scores in the NRS scale analytic study in patients examined at the Outpatient Ortho- and Roland- Morris Questionnaire were higher in the study pedics and Plastic Surgery Departments at Samuel Libânio group when compared to the control group. Conclusion – The University Hospital in Pouso Alegre, MG. 100 women were results achieved showed that back pain is more severe and examined, 50 presenting breast hypertrophy (study group) determined more extensive limitations in the daily activities and 50 with normal breast size (control group). Breasts were for patients presenting breast hypertrophy. classified according to Sacchini’s criteria. The Numerical Ra- ting Scale (NRS) and the Roland-Morris questionnaire were Keywords: Back pain; Quality of life; Neck pain; Breast. Citation: Fernandes PM, Sabino Neto M, Veiga DF, Abla LEF, Mundim CDA, Juliano Y et al. Back pain: an assessment in breast hypertrophy patients. Acta Ortop Bras. [serial on the Internet]. 2007; 15(4): 227-230. Available from URL: http://www.scielo.br/aob.
    [Show full text]
  • Journal of Clinical Review & Case Reports
    ISSN: 2573-9565 Case Report Journal of Clinical Review & Case Reports Pseudo Angiomatous Stromal Hyperplasia of the Breast: A Case of A 19-Year-Old Asian Girl Yuzhu Zhang1, Weihong Zhang2# , Yijia Bao1, Yongxi Yuan1,3* 1Department of Mammary gland, Longhua Hospital Affiliated to Shanghai University of TCM, Shanghai, China *Corresponding author 2Department of Mammary gland, Baoshan branch of Shuguang Yongxi Yuan, Department of Mammary gland, Longhua Hospital Hospital Affiliated to Shanghai University of TCM, Shanghai,201900, Affiliated to Shanghai University of TCM & Huashan Hospital, China. Shanghai Medical College, Fudan University, Shanghai, China. Tel: +8602164383725; Email: [email protected] 3Department of Mammary gland, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China Submitted: 11 Oct 2017; Accepted: 20 Oct 2017; Published: 04 Nov 2017 #co-first author Abstract Pseudoangiomatous stromal hyperplasia (PASH), a benign disease with extremely low incidence, is manifested as giant breasts, frequent relapse after surgery, or endocrine disorder. Cases with unilateral breast and undetailed endocrine condition have been reported in African and American. In this case, a 19-year-old Asian girl suffered from bilateral breast PASH after the human placenta and progesterone treatment for 3-month delayed menstruation. Her breasts enlarged remarkably 1 month after the treatment, with extensive inflammatory swell in bilateral mammary glands and subcutaneous edema in retromammary space. The patient received the bilateral quadrantectomy plus breast reduction and suspension surgery to terminate the progressive hyperplasia of breast. During the whole treatment period, the patient was given tamoxifen treatment for 4 months, and endocrine levels were intensively recorded. The follow-up after 4 months showed recovered breast with normal shape and size, and there was no distending pain, a tendency toward breast hyperplasia, or menstrual disorder.
    [Show full text]
  • Juvenile Breast Hypertrophy
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Via Medica Journals ONLINE FIRST This is a provisional PDF only. Copyedited and fully formatted version will be made available soon. ISSN: 0423-104X e-ISSN: 2299-8306 Juvenile breast hypertrophy Authors: Benedita Bianchi de Aguiar, Rita Santos Silva, Carla Costa, Cintia Castro-Correia, Manuel Fontoura DOI: 10.5603/EP.a2019.0063 Article type: Clinical Vignette Submitted: 2019-12-07 Accepted: 2019-12-16 Published online: 2020-01-07 This article has been peer reviewed and published immediately upon acceptance. It is an open access article, which means that it can be downloaded, printed, and distributed freely, provided the work is properly cited. Articles in "Endokrynologia Polska" are listed in PubMed. The final version may contain major or minor changes. Powered by TCPDF (www.tcpdf.org) Juvenile breast hypertrophy Benedita Bianchi de Aguiar1, Rita Santos Silva2, Carla Costa2, Cintia Castro-Correia2, Manuel Fontoura2 1Paediatrics Department, Centro Hospital Entre Douro e Vouga, Portugal 2Paediatrics Endocrinology, Centro Hospitalar Universitário de São João, Portugal Correspondence to: Benedita Sousa Amaral Bianchi de Aguiar, Rua Marta Mesquita da Câmara 175 Apt 62 4150-485 Porto, Portugal, tel: (+351) 913 166 913; e-mail: [email protected] Case description Juvenile breast hypertrophy (JBH), also called virginal hypertrophy or macromastia, is a rare benign condition, in which one or both breasts undergo a massive increase in size duringin puberty, usually around menarche. We present a clinical case of JBH and discuss the available therapeutic options. An 11-year- old female patient was referred to our paediatric endocrinologist consultant due to breast hypertrophy.
    [Show full text]
  • W O 2019/232146 Al 05 December 2019 (05.12.2019) W IPO I PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property (1) Organization11111111111111111111111I1111111111111i1111liiiii International Bureau (10) International Publication Number (43) International Publication Date W O 2019/232146 Al 05 December 2019 (05.12.2019) W IPO I PCT (51) International Patent Classification: JIANG, Zaoli; 20 Cedar Rock Road, Woodbridge, Con A61K31/19(2006.01) A61K45/00(2006.01) necticut06525(US). A61K38/12 (2006.01) A61K 45/08 (2006.01) (74) Agent: DOYLE, Kathryn et al.; Saul Ewing Arnstein & (21) International Application Number: Lehr LLP, 1500 Market Street, 38th Floor, Philadelphia, PCT/US2019/034548 Pennsylvania 19102 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 30 May 2019 (30.05.2019) kind ofnational protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (25)FilingLanguage: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (26) Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (30)PriorityData: HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (30)/Priority : 01 June 2018 (01.06.2018) us KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (71) Applicant: YALE UNIVERSITY [US/US]; Two Whitney OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, Avenue, New Haven, Connecticut 06510 (US). SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, ZA, ZM, ZW.
    [Show full text]
  • Chronic Cystic Mastitis with Special Relation to Carcinoma
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1937 Chronic cystic mastitis with special relation to carcinoma John D. Hamer University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Hamer, John D., "Chronic cystic mastitis with special relation to carcinoma" (1937). MD Theses. 512. https://digitalcommons.unmc.edu/mdtheses/512 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. CHRONIC CYSTIC IvIASTITIS va th Special Relation to Carcinoma Senior Tbesis Presented to the University of Nebraska College of Medicine by .John D. Hamer INTRODUCTION The purpose of this paper is to better acquaint the student wi th the ever changing views of investigators regarding the relationship of Chronic cystic mastitis to carcinoma of the breast. The Buthor has borne in mind that until recent years very little work of an experimental nature has been done in this field. Consequently the material from which this paper is made up has been ex­ tracted from current articles upon this subject. He has set down clinical find­ ings, experimental results, and theories of the different workers with an open mind. He has tried not to form an opin­ ion but would rather let the reader form come to his own conclusions, 480871 CHRONIC CYSTIC 1MSTITIS Definition - Chronic Cystic Mastitis is a misnomer.
    [Show full text]
  • Pediatric and Adolescent Breast Masses
    Pediatric Imaging • Review Kaneda et al. Pediatric and Adolescent Breast Masses Pediatric Imaging Review Pediatric and Adolescent Breast Masses: A Review of Pathophysiology, Imaging, Diagnosis, and Treatment Heather J. Kaneda1 OBJECTIVE. Pediatric breast masses are relatively rare and most are benign. Most are Julie Mack either secondary to normal developmental changes or neoplastic processes with a relatively Claudia J. Kasales benign behavior. To fully understand pediatric breast disease, it is important to have a firm Susann Schetter comprehension of normal development and of the various tumors that can arise. Physical ex- amination and targeted history (including family history) are key to appropriate patient man- Kaneda HJ, Mack J, Kasales CJ, Schetter S agement. When indicated, ultrasound is the imaging modality of choice. The purpose of this article is to review the benign breast conditions that arise as part of the spectrum of normal breast development, as well as the usually benign but neoplastic process that may develop within an otherwise normal breast. Rare primary carcinomas and metastatic lesions to the pediatric breast will also be addressed. The associated imaging findings will be reviewed, as well as treatment strategies for clinical management of the pediatric patient with signs or symptoms of breast disease. CONCLUSION. The majority of breast abnormalities in the pediatric patient are be- nign, but malignancies do occur. Careful attention to patient presentation, history, and clini- cal findings will help guide appropriate imaging and therapeutic decisions. hough breast masses are uncom- mary breast cancer is extremely low in the pe- mon in the pediatric population, diatric population, reducing the utility of mam- the detection of an abnormality is mography as a diagnostic problem-solving tool T often alarming to caregivers and [1].
    [Show full text]
  • Laktation & Stillen
    LactationLaktation & Breastfeeding & Stillen ZeitschriftMagazine der of theEuropäischen European LactationLaktationsberaterinnen Consultants Alliance Allianz • www.elacta.eu • ISSNISSN 1614-807x1614-807x COVER STORY PRACTICAL KNOW HOW PRACTICAL KNOW HOW Breastfeeding After Cosmetic Infant Hand Movements During Do Mothers Really Have The Choice th Breast Surgery – page 15 Breast Seeking – page 6 To Breastfeed? – page 10 3 • 2017 30 Volume Foto: Field exchange 48 2 EDITORIAL EDITORIAL Dear members, dear colleagues, dear readers, IMPRINT summer has gone, it has started raining, the wind is blow- Company Information: ELACTA European Lactation ing and leaves are falling from trees. In this ELACTA mag- Consultants Alliance azine you will find some nice issues to read about, even by www.elacta.eu authors from overseas. About situations that will come up Email: [email protected] ZVR-Nr.: 708420941 unexpectedly and are sometimes unwanted. Our profession is really important, also after hospitalization. Convince your ELACTA president: Karin Tiktak, IBCLC colleagues and other health care providers about the impor- [email protected] tant role you play as an IBCLC. Editorial and project Actually the ELACTA board is writing this editorial from coordination: Opatija in Croatia. It is a beautiful place where one of our Eva Bogensperger-Hezel, IBCLC board members lives and does her job as an IBCLC in her pri- Email: [email protected] vate practice. We have board meetings on Friday and Saturday Team: from 9 am to 5 pm. During this enjoyable time together, we Andrea Hemmelmayr, IBCLC Elke Cramer, Ärztin, IBCLC bridge the differences we experience in lactational care. Be- Kathrin Meier, IBCLC ing the president of this important association makes me feel Bärbel Waldura, IBCLC grateful and responible.
    [Show full text]
  • Gynecomastia Info
    Page 1 of 4 GYNECOMASTIA TYPES AND TREATMENTS by JAMES ROMANO, MD Gynecomastia is usually strictly defined as the visible or palpable development of breast tissue in men. The term comes from the Greek words gyne meaning "woman" and mastos meaning "breast." In practical terms, this means abnormally large breasts on men. This is often related to the occurrence of excess fat or, less frequently, overdeveloped muscles. The condition is relatively common in adolescent boys, and 90% of the time symptoms disappear in a matter of months, or, as adolescence wanes, a few years later. But the remaining 10% are burdened with a social handicap that causes a deep and complex shame, and often puts a man’s relationship with his body into an altered state. Drugs, medications, hormonal imbalance, genetic conditions, and exogenous hormones can all cause gynecomastia. During puberty it is normal for most boys to develop some proliferation of breast tissue. This is often make known by the onset of pain in the nipples or sub-areolar region. Ordinarily this condition is self-limited and subsides within 6 to 18 months. When this gynecomastia persists, it is often embarrassing and psychologically debilitating. Removal of the excess breast parenchyma is the only effective treatment. This condition can be accentuated if the patient is overweight. Marijuana usage is commonly linked to gynecomastia. Men who are taking estrogens or testosterone inhibitors because of prostate cancer or patients with liver disease who have a hormonal imbalance are also susceptible to this condition. Gynecomastia can develop as a result of taking anabolic steroids to enhance athletic performance or bodybuilding.
    [Show full text]
  • Neonatal Breast Hypertrophy
    & The ics ra tr pe a u i t i d c e s P Pediatrics & Therapeutics Donaire et al., Pediatr Ther 2016, 6:3 ISSN: 2161-0665 DOI: 10.4172/2161-0665.1000297 Case Report Open Access Neonatal Breast Hypertrophy: Revisited Alvaro Donaire, Juan Guillen and Benamanahalli Rajegowda* Department of Pediatrics, Lincoln Medical and Mental Health Center, USA *Corresponding author: Benamanahalli Rajegowda, Department of Pediatrics, Division of Neonatology, Lincoln Medical and Mental Health Center, 234 East 149th Street, Bronx, New York, 10451, USA, Tel: 718-579-5360; Fax: 718-579-4958; E-mail: [email protected] Received date: Jun 28, 2016, Accepted date: Jul 14, 2016, Published date: Jul 18, 2016 Copyright: © 2016 Donaire A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. Introduction Neonatal breast enlargement is a benign condition that may be seen during the first days of life in the neonatal period and it has been reported to occur in 65-90% of infants. Within few months after birth it usually involutes, and later regrows during puberty due to hormonal stimulation. Breast enlargement is uncommon, when it occurs is a benign physical finding [1]. Neonatal galactorrhea, commonly referred to as witch’s milk, is a cloudy discharge from the breasts that occurs when estrogen and progesterone levels decrease after delivery, enabling the secretion of prolactin and oxytocin from the neonate’s pituitary [2]. The “witch’s milk” resembles the maternal milk composition, the milk comes only when the breast are expressed.
    [Show full text]
  • Macromastia - Reduction Mammoplasty
    Macromastia - Reduction Mammoplasty Reduction mammoplasty or breast reduction surgery reduces the volume and weight of the breasts by removing excess fat, glandular tissue and skin. The procedure is performed in ​ order to alleviate or correct medical problems caused by excessive breast tissue. Women ​ presenting with various forms of breast hypertrophy accompanied by persistent clinical signs and symptoms that adversely affect health are the principal candidates for breast reduction surgery. Note: Reduction mammoplasty performed as part of gender affirming surgeries are NOT ​ covered under this clinical criteria. Reduction mammoplasty will be considered for coverage when ALL of the criteria below are ​ met, confirmed with supporting medical documentation. I. Criteria for Initial Approval ● Documentation of a functional impairment (defined as adverse effect on activities of daily living) related to at least two of the following: ​ ​ ○ Chronic pain ■ Chronic headaches. ■ Chronic upper back, neck, breast or shoulder pain. ○ Skin changes ■ Signs and symptoms of intertriginous maceration and/or infection of the inframammary skin (e.g., hyperpigmentation, bleeding, chronic moisture, and evidence of skin breakdown refractory to dermatologic measures). ■ Shoulder grooving from bra straps. ○ Arthritic changes ■ Signs and symptoms of nerve compression that are unresponsive to medical management (e.g., ulnar paresthesias) and evidenced ​ by nerve conduction studies. ■ History of significant arthritic changes in the cervical or upper thoracic spine. ■ Thoracic outlet syndrome. ■ Acquired kyphosis that is attributed to macromastia. ○ Dysmorphic Syndrome ■ Depression/significant anxiety related to macromastia. 1 ● Medical opinion that these functional impairments are attributable to macromastia. ○ Documented exclusion of alternative etiologies (e.g., such as arthritis, multiple sclerosis, cervical spine disease, etc.) have been adequately ruled-out by means of diagnostics, as applicable.
    [Show full text]
  • Breast Diseases in Children: the Spectrum of Radiologic Findings in a Cohort Study
    Diagn Interv Radiol 2017; 23:407–413 BREAST IMAGING © Turkish Society of Radiology 2017 ORIGINAL ARTICLE Breast diseases in children: the spectrum of radiologic findings in a cohort study Emel Durmaz PURPOSE Murat Alp Öztek We aimed to investigate the spectrum of radiologic findings and referral reasons for breast dis- Hatice Arıöz Habibi eases in children considering age-appropriate presentation. Uğur Kesimal METHODS Hakkı Timur Sindel Our retrospective cohort study included 348 consecutive pediatric patients aged <19 years (me- dian, 13 years) referred to radiology with a clinical presentation between 2005 and 2016. Radio- logic findings were reviewed in four age ranges (0–2 years, 2–8 years, 8–15 years, >15 years). RESULTS Of 348 patients, 257 had a referral reason. The most frequent referral reason was a palpable mass (35%). Developmental abnormalities accounted for 48% of all radiologic findings in 348 patients. We did not detect any breast malignancy. According to age groups, the most common radiologic findings were neonatal hypertrophy (0–2 years), early breast development (2–8 years), develop- mental abnormalities by a majority of gynecomastia (8–15 years), and normal findings or devel- opmental abnormalities (>15 years). Interestingly, the frequency of gynecomastia was only 4% in neonatal period or early childhood. Fibroadenomas and fibroadenoma-like solid masses were seen after 8 years and constituted the majority of solid masses (65%). Cysts were seen at a rate of 7% and majority of them were of simple type, which tends to resolve in time. CONCLUSION In our study, the most common referral reason to radiology was a palpable breast mass.
    [Show full text]
  • Neonatal Mastauxe (Breast Enlargement of the Newborn)
    Journal of Neonatal Surgery 2013;2(3):31 ATHENA’S PAGES Neonatal Mastauxe (Breast Enlargement of the Newborn) V. Raveenthiran Department of Pediatric Surgery, Sri Ramasamy Memorial (SRM) Medical College, SRM University, Chennai 603203, India (Athena stands for abbreviation of Abstracting and Thoughtful Evaluation of Neonatal Articles; but it is also personified by the contributor. Like Athena of Greek mythology, she distills wisdom from published literature) Maternal estrogen is known to cause varying lactalbumin [6]. Inadequate let-out of milk, ei- degree of breast enlargement in approximately ther due to improper canalization of lactiferous 70% of newborn. [1] Usually the diameter of ducts or due to lack of oxytocin stimulus in the breast bud measures 1 to 2 cm in the first few newborn, may lead to stagnation of milk weeks of life [2]. But Athena has seen some of (galactocele). Superadded infection may result these breasts of alarming size (Figure 1). in complications such as mastitis and breast abscess [7]. Athena intends to update the re- cent developments on this oddity of the Nature. An extensive review of literature has left Athena much disappointed for many reasons. First of all, there is no proper terminology to describe uncomplicated, physiological enlargement of breasts in the newborn. Research papers sel- dom distinguish various forms of breast swell- ings in newborn such as physiological enlarge- ment, exaggerated development, bulging galactocele, inflammatory swelling and breast abscess. Terms such as ‘mastitis’ [8,9,10], ‘galactorrhea’ [4,11], ‘gynecomastia’ [11,12], ‘galactocele’ [12,13], ‘breast hypertrophy’[14] and ‘breast enlargement’[1] have been used in- terchangeably to denote any of the aforemen- Figure 1: Giant Mastauxe of newborn.
    [Show full text]